LOMBARDI, RAFFAELLA
 Distribuzione geografica
Continente #
AS - Asia 2.384
NA - Nord America 1.866
EU - Europa 1.313
SA - Sud America 290
AF - Africa 48
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.906
Nazione #
US - Stati Uniti d'America 1.809
SG - Singapore 1.083
RU - Federazione Russa 633
VN - Vietnam 453
CN - Cina 413
IT - Italia 240
BR - Brasile 231
HK - Hong Kong 182
DE - Germania 78
NL - Olanda 69
FR - Francia 62
UA - Ucraina 61
JP - Giappone 49
FI - Finlandia 42
KR - Corea 35
BD - Bangladesh 33
IN - India 31
AR - Argentina 25
CA - Canada 25
GB - Regno Unito 23
IE - Irlanda 22
MX - Messico 17
PL - Polonia 17
ZA - Sudafrica 15
AT - Austria 14
IQ - Iraq 13
SE - Svezia 12
PH - Filippine 11
EC - Ecuador 9
ID - Indonesia 9
TW - Taiwan 9
UZ - Uzbekistan 9
ES - Italia 7
CI - Costa d'Avorio 6
CO - Colombia 6
PK - Pakistan 6
PY - Paraguay 6
TH - Thailandia 6
BG - Bulgaria 5
MY - Malesia 5
SA - Arabia Saudita 5
AL - Albania 4
BE - Belgio 4
CL - Cile 4
EG - Egitto 4
MA - Marocco 4
NP - Nepal 4
TN - Tunisia 4
VE - Venezuela 4
CR - Costa Rica 3
GE - Georgia 3
IL - Israele 3
KE - Kenya 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
AF - Afghanistan, Repubblica islamica di 2
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
GA - Gabon 2
GF - Guiana Francese 2
JO - Giordania 2
KH - Cambogia 2
LC - Santa Lucia 2
LV - Lettonia 2
ML - Mali 2
PE - Perù 2
PT - Portogallo 2
SI - Slovenia 2
TR - Turchia 2
BJ - Benin 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MR - Mauritania 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
Totale 5.898
Città #
Singapore 577
San Jose 309
Hong Kong 179
Moscow 159
Santa Clara 153
Ashburn 151
Chandler 139
Ho Chi Minh City 119
Hefei 117
Beijing 108
Hanoi 98
Naples 70
The Dalles 68
Amsterdam 58
Los Angeles 54
Jacksonville 52
Lauterbourg 52
Boston 44
Tokyo 44
Millbury 36
Woodbridge 35
Munich 33
Buffalo 25
Lawrence 25
Redondo Beach 25
Des Moines 24
Seoul 24
Da Nang 21
Princeton 21
São Paulo 21
Rome 19
Nanjing 18
Council Bluffs 17
Haiphong 17
Wilmington 17
Dong Ket 16
New York 16
Denver 15
Florence 15
Houston 15
Dallas 12
Dublin 11
Turku 11
Warsaw 11
Atlanta 10
Brooklyn 10
Napoli 10
Orem 10
Brasília 9
Mexico City 9
Milan 9
Rio de Janeiro 9
Tashkent 9
Belo Horizonte 8
Hải Dương 8
Lappeenranta 8
Nuremberg 8
Chicago 7
Baghdad 6
Capaccio 6
Charlotte 6
Frankfurt am Main 6
London 6
Montreal 6
Thái Nguyên 6
Turin 6
Bình Phước 5
Bắc Giang 5
Chennai 5
Fairfield 5
Helsinki 5
Mugnano di Napoli 5
Mumbai 5
Phoenix 5
Poplar 5
San Francisco 5
Seattle 5
Stockholm 5
Thái Bình 5
Toronto 5
Vienna 5
Ann Arbor 4
Can Tho 4
Cernobbio 4
Curitiba 4
Delhi 4
Falkenstein 4
Goiânia 4
Guangzhou 4
Hebei 4
Nanchang 4
Nha Trang 4
Ottawa 4
Quận Ba 4
Salt Lake City 4
Shanghai 4
Shenyang 4
Sofia 4
Tân Tiến 4
Biên Hòa 3
Totale 3.373
Nome #
Myocardial collagen turnover in hypertrophic cardiomyopathy 165
Dobutamine stress echocardiography in hypertrophic cardiomyopathy 160
Global longitudinal strain in pre-symptomatic patients with mutation for transthyretin amyloidosis 158
Echocardiographic Strain Abnormalities Precede Left Ventricular Hypertrophy Development in Hypertrophic Cardiomyopathy Mutation Carriers 140
Sarcomeric versus Non-Sarcomeric HCM 134
Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting 132
Speckle-tracking analysis based on 2D echocardiography does not reliably measure left ventricular torsion 131
Diagnosis and Treatment of Obstructive Hypertrophic Cardiomyopathy 130
Diagnosis and Clinical Implication of Left Ventricular Aneurysm in Hypertrophic Cardiomyopathy 128
Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy 126
Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects 126
Aetiology and pathogenesis of hypertrophic cardiomyopathy 125
Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. 125
Myocardial collagen turnover in hypertrophic cardiomyopathy 125
Myocardial texture in hypertrophic cardiomyopathy 123
Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging 121
Artificial intelligence-driven electrocardiography: Innovations in hypertrophic cardiomyopathy management 120
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy 119
Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation 119
Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes 112
Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review 110
Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy. 110
Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. 109
Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function 107
Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes 107
Characterization of Hypertrophic Cardiomyopathy Caused by Mutations in Four and a Half Lim Domains 1 Gene 106
Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy 102
Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy 101
Clinical significance of diastolic dysfunction and the effect of therapeutic interventions 100
[Myocardial interstitial fibrosis and diastolic dysfunction in hypertrophic cardiomyopathy]. 99
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 98
Mechano-energetic efficiency in patients with hypertrophic cardiomyopathy with and without sarcomeric mutations 96
Knock Down of Plakophillin 2 Dysregulates Adhesion Pathway through Upregulation of miR200b and Alters the Mechanical Properties in Cardiac Cells 91
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: A pilot study 91
Comparison of hemodynamic adaptation to orthostatic stress in patients with hypertrophic cardiomyopathy with or without syncope and in vasovagal syncope 90
Myocardial interstitial fibrosis and diastolic dysfunction in hypertrophic cardiomyopathy,Fibrosi interstiziale miocardica e disfunzione diastolica nella cardiomiopatia ipertrofica 88
Arrhythmogenic Cardiomyopathy and Skeletal Muscle Dystrophies: Shared Histopathological Features and Pathogenic Mechanisms 82
DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated with LMNA (Lamin A/C) Mutations 78
Human molecular genetic and functional studies identify TRIM63, encoding muscle RING finger protein 1, as a novel gene for human hypertrophic cardiomyopathy 76
Cardiac fibro-adipocyte progenitors express desmosome proteins and preferentially differentiate to adipocytes upon deletion of the desmoplakin gene 73
Knockdown of plakophilin 2 downregulates MIR-184 through CpG hypermethylation and suppression of the E2F1 pathway and leads to enhanced adipogenesis in vitro 71
Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy 70
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis 70
Filamin C Deficiency Impairs Sarcomere Stability and Activates Focal Adhesion Kinase through PDGFRA Signaling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes 69
Identification of Genes and Pathways Regulated by Lamin A in Heart 68
Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype 66
Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy 66
The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy 65
Editorial of Special Issue “Genetics and Molecular Pathogenesis of Non-Ischemic Cardiomyopathies” 65
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy 63
Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies 62
Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells 62
Established and emerging mechanisms in the pathogenesis of arrhythmogenic cardiomyopathy: A multifaceted disease 61
Suppression of activated FOXO transcription factors in the heart prolongs survival in a mouse model of laminopathies. 60
Genetics and sudden death 59
Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy 56
Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy 56
Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy 53
Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy 53
Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: A disease of cardiac stem cells 53
Molecular and cellular mechanisms in heart failure including models of heart failure 51
A polygenic risk score after corrective surgery for transposition of the great arteries: Can genetics add value to clinical predictors of outcome? 50
Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity 49
NFkB1 Pathway is a Major Dysregulated Biological Pathway in Cardiac Myocytes in Myocyte-Specific Lamin A/C Deficient Mice 47
Parallel Neurological and Cardiac Progression in Hereditary Transthyretin Amyloidosis: An Integrated Clinical and Imaging Study 28
Arrhythmic risk in mitral valve prolapse with mitral annular disjunction: meta-analysis of longitudinal studies 5
Left atrial size trajectories and outcome over a 35-year follow-up in patients with hypertrophic cardiomyopathy 4
Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy 3
Reverse septal curvature in hypertrophic cardiomyopathy: Implications for function, structure and arrhythmic risk 2
Totale 6.020
Categoria #
all - tutte 19.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022220 0 0 0 0 0 7 0 11 21 36 40 105
2022/2023334 48 24 17 11 46 35 0 33 38 59 17 6
2023/2024202 6 31 46 12 9 10 2 18 2 2 40 24
2024/20251.684 88 150 2 15 92 86 200 119 78 139 542 173
2025/20263.212 310 292 325 281 497 132 364 239 387 245 112 28
Totale 6.020